Valuation in Life Sciences

A Practical Guide

3rd Edition

By Boris Bogdan , Ralph Villiger

Valuation in Life Sciences Cover Image

Here, in an updated edition with new examples, is a complete guide to valuation in life sciences. Using real-life cases, the authors show how to value projects, patents, licences, firms and stocks, including complex licence and company structures.

Full Description

  • ISBN13: 978-3-6421-0819-8
  • 384 Pages
  • Publication Date: April 19, 2010
  • Available eBook Formats: PDF
  • eBook Price: $89.95
Buy eBook Buy Print Book Add to Wishlist
Full Description
This book is the first complete guide to valuation in life sciences for industry professionals, investors, and academics. Boris Bogdan and Ralph Villiger introduce the characteristics of drug and medical device development, explain how to translate these into the valuation, and provide valuable industry data. After guiding the reader through the theory of valuation, including DCF, decision trees, and real options, the authors demonstrate how to value projects, patents, licences, firms, and stocks on real-life examples, even treating complex licence and company structures. Special emphasis is put on the practicability of the proposed methods by including many hands-on examples, without compromising on realistic results. The 3rd edition of the successful work includes new studies about success rates and about drug development in the biotech industry and their influence on valuation.
Table of Contents

Table of Contents

  1. Introduction.
  2. The Life Sciences Industry.
  3. Valuation.
  4. Project Valuation.
  5. License Contract Valuation.
  6. Technology Valuation.
  7. IP Valuation.
  8. Firm Valuation.
  9. Advanced Topics.
  10. Valuation and Gut Feeling.
  11. Excercises.
Errata

Please Login to submit errata.

No errata are currently published